Cargando…

Incidence of deep vein thrombosis among non‐ICU patients hospitalized for COVID‐19 despite pharmacological thromboprophylaxis: Response from original authors Pola et al

Detalles Bibliográficos
Autores principales:	Porfidia, Angelo, Santoliquido, Angelo, Cammá, Giulia, Porceddu, Enrica, Pola, Roberto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. 2020
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9770780/ https://www.ncbi.nlm.nih.gov/pubmed/32860325 http://dx.doi.org/10.1111/jth.15089

Ejemplares similares

Differences in Clinical Presentation, Rate of Pulmonary Embolism, and Risk Factors Among Patients With Deep Vein Thrombosis in Unusual Sites
por: Porfidia, Angelo, et al.
Publicado: (2019)

A Single Center Retrospective Cohort Study Comparing Different Anticoagulants for the Treatment of Catheter-Related Thrombosis of the Upper Extremities in Women With Gynecologic and Breast Cancer
por: Porfidia, Angelo, et al.
Publicado: (2022)

CT Pulmonary Angiography for the Diagnosis of Pulmonary Embolism in Patients with COVID-19: When, Why, and for Who?
por: Porfidia, Angelo, et al.
Publicado: (2021)

Second wave of the COVID-19 pandemic: D-dimer levels are not so high anymore
por: Porfidia, Angelo, et al.
Publicado: (2021)

High-dose versus low-dose venous thromboprophylaxis in hospitalized patients with COVID-19: a systematic review and meta-analysis
por: Valeriani, Emanuele, et al.
Publicado: (2022)

Pulmonary Embolism in COVID-19 Patients: Which Diagnostic Algorithm Should We Use?
por: Porfidia, Angelo, et al.
Publicado: (2021)

Low-Dose Rivaroxaban to Prevent Recurrences of Venous Thromboembolism in Cancer: A Real-Life Experience with a Focus on Female Patients
por: Santini, Paolo, et al.
Publicado: (2023)

The challenge of pharmacological thromboprophylaxis in ICU patients: anti-FXa activity does not constitute the simple solution. Author's reply
por: Hofmaenner, Daniel A., et al.
Publicado: (2022)

Prevalence of pulmonary embolism on hospital admission in COVID-19 patients: is there a role for pre-test probability scores and home treatment?
por: Porfidia, Angelo, et al.
Publicado: (2021)

Venous thromboembolism and heparin use in COVID-19 patients: juggling between pragmatic choices, suggestions of medical societies and the lack of guidelines
por: Porfidia, Angelo, et al.
Publicado: (2020)

Correction to: Venous thromboembolism and heparin use in COVID-19 patients: juggling between pragmatic choices, suggestions of medical societies and the lack of guidelines
por: Porfidia, Angelo, et al.
Publicado: (2020)

Deep vein thrombosis and thromboprophylaxis in arthroscopic anterior cruciate ligament reconstruction
por: Adala, Raviraj, et al.
Publicado: (2011)

Non‐severe COVID‐19 is associated with endothelial damage and hypercoagulability despite pharmacological thromboprophylaxis
por: Kelliher, Sarah, et al.
Publicado: (2022)

Pola Weiss : pionera del videoarte en México /
por: Hernández Miranda, Dante, 1973-
Publicado: (2000)

COVID-19 Is Associated with Endothelial Dysfunction and Enhanced Plasma Thrombin Generation Despite Pharmacological Thromboprophylaxis
por: Kelliher, Sarah, et al.
Publicado: (2021)

Systemic thrombosis in a large cohort of COVID-19 patients despite thromboprophylaxis: A retrospective study
por: Muñoz-Rivas, Nuria, et al.
Publicado: (2021)

Retinal Vein Thrombosis despite Treatment for Hypertension
por: Alvarez, E., et al.
Publicado: (1984)

Pharmacological thromboprophylaxis and epidural anaesthesia
por: Harsoor, SS, et al.
Publicado: (2012)

Mechanical thromboprophylaxis is sufficient to prevent the lower extremity deep vein thrombosis after kidney transplantation
por: Jun, Kang-Woong, et al.
Publicado: (2014)

Systematic Review and Meta-analysis of the Additional Benefit of Pharmacological Thromboprophylaxis for Endovenous Varicose Vein Interventions
por: Turner, Benedict R. H., et al.
Publicado: (2023)

Venous thromboembolism in the ICU: main characteristics, diagnosis and thromboprophylaxis
por: Minet, Clémence, et al.
Publicado: (2015)

No evidence of increased rate of thrombotic recurrences in patients with history of venous thromboembolism after vaccination for COVID-19
por: Porfidia, Angelo, et al.
Publicado: (2022)

Prevalence of Low Limb Venous Thromboembolic Events in Mild and Severe/Critically Ill Patients with COVID-19 Despite Pharmacological Thromboprophylaxis
por: Zhang, Cong, et al.
Publicado: (2020)

Thromboprophylaxis for Deep Vein Thrombosis and Pulmonary Embolism after Total Joint Arthroplasty in a Low Incidence Population
por: Kim, Kang-Il, et al.
Publicado: (2013)

Incidence and Nature of Lower-Limb Deep Vein Thrombosis in Patients with Polytrauma on Thromboprophylaxis: A Prospective Cohort Study
por: Chowdhury, Sharfuddin, et al.
Publicado: (2021)

Is delaying pharmacological thromboprophylaxis associated with thromboembolic complications?
por: Padim, P, et al.
Publicado: (2015)

Pharmacologic therapeutic options for thromboprophylaxis in COVID-19
por: Kow, Chia Siang, et al.
Publicado: (2020)

Thromboprophylaxis in lower limb varicose vein surgery in Brazil
por: Ribeiro, Alcides José Araújo, et al.
Publicado: (2022)

Thromboembolic risk factors and thromboprophylaxis in a medical–surgical ICU in Mexico
por: Perez-Rada, FJ, et al.
Publicado: (2009)

Plasma D-dimer is not useful in the prediction of deep vein thrombosis after total knee arthroplasty in patients using rivaroxaban for thromboprophylaxis
por: Wu, Cheng-Ta, et al.
Publicado: (2018)

Acute high-risk pulmonary embolism requiring thrombolytic therapy in a COVID-19 pneumonia patient despite intermediate dosing deep vein thromboprophylaxis
por: Salam, Shameen, et al.
Publicado: (2020)

Free Flap Survival Despite Internal Jugular Vein Thrombosis in Head and Neck Reconstruction
por: Kiya, Koichiro, et al.
Publicado: (2018)

Knockdown of POLA2 increases gemcitabine resistance in lung cancer cells
por: Koh, Vivien, et al.
Publicado: (2016)

Involvement of POLA2 in Double Strand Break Repair and Genotoxic Stress
por: Dang, Tuyen T., et al.
Publicado: (2020)

Incidences of deep vein thrombosis and major bleeding under the administration of fondaparinux for thromboprophylaxis after periacetabular osteotomy: a retrospective observational study
por: Fukushima, Kensuke, et al.
Publicado: (2021)

Venous thromboembolism in patients with COVID-19: Systematic review and meta-analysis
por: Porfidia, Angelo, et al.
Publicado: (2020)

Characteristics of Anaplastic Oligodendrogliomas Short-Term Survivors: A POLA Network Study
por: Garnier, Louis, et al.
Publicado: (2022)

New Phage-Derived Antibacterial Enzyme PolaR Targeting Rothia spp.
por: Miernikiewicz, Paulina, et al.
Publicado: (2023)

Renal function in the ICU: always look both ways before initiating venous thromboprophylaxis
por: Baptista, João Pedro, et al.
Publicado: (2023)

Antithrombotic Therapy in Hereditary Hemorrhagic Telangiectasia: Real-World Data from the Gemelli Hospital HHT Registry
por: Gaetani, Eleonora, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_otevoladd6fj56s94b87ig0tcr